Results 31 to 40 of about 101,164 (260)
Cancer Treatment and Research Communications, 2020 Introduction: Microglandular adenosis (MGA) is a rare benign proliferative lesion lacking a myoepithelial cell layer; 27% of all reported cases have progressed to invasive carcinoma.
Victoria Rico +8 more
doaj +1 more source
, 2022 BackgroundAdenoid cystic carcinoma (ACC) is a rare type of triple-negative breast cancer that has an indolent clinical behavior. Given the substantial overlapping morphological, immunohistochemical, and molecular features with other basal-like triple ...
Qian Yao (1451017) +8 more
core +1 more source
Zhongliu Fangzhi Yanjiu, 2020 Objective To investigate the association between family history of malignant neoplasms (MN-FH) and clinicopathological characteristics of patients with breast cancer.
CAO Xinhua +4 more
doaj +1 more source
Current Issues and Clinical Evidence in Tumor-Infiltrating Lymphocytes in Breast Cancer [PDF]
Journal of Pathology and Translational Medicine, 2015 With the advance in personalized therapeutic strategies in patients with breast cancer, there is an increasing need for biomarker-guided therapy. Although the immunogenicity of breast cancer has not been strongly considered in research or practice, tumor-
Sung Gwe Ahn +3 more
doaj +1 more source
Defining triple‐negative breast cancer with neuroendocrine differentiation (TNBC‐NED)
, 2023 Primary breast neuroendocrine (NE) neoplasms are uncommon, and definitions harbor controversy. We retrospectively collected 73 triple‐negative breast cancers (TNBC) and evaluated NE biomarker expression along with p53 aberrant staining (which correlates ...
Sean M Hacking +2 more
core +1 more source
CAR-T cell therapy in triple-negative breast cancer: Hunting the invisible devil
Frontiers in Immunology, 2022 Triple-negative breast cancer (TNBC) is known as the most intricate and hard-to-treat subtype of breast cancer. TNBC cells do not express the well-known estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2 ...
Fatemeh Nasiri +10 more
doaj +1 more source
Adenosquamous Variant of Metaplastic Carcinoma of Breast – An Unusual Histological Variant [PDF]
Journal of Clinical and Diagnostic Research, 2015 Metaplastic carcinoma of breast refers to a heterogeneous group of neoplasms characterized by intimate admixture of adenocarcinoma with dominant areas of spindle cell, squamous cell and/ or mesenchymal differentiation.
P.U.Swathy +4 more
doaj +1 more source
The spectrum of triple-negative breast disease: high- and low-grade lesions
, 2017 Triple-negative breast cancer is viewed clinically as an aggressive subgroup of breast cancer. In fact, most triple-negative breast cancers are poor-prognosis tumors with a complex genomic landscape.
Reis-Filho, Jorge S. +13 more
core +1 more source
Nestin expression associates with poor prognosis and triple negative phenotype in locally advanced (T4) breast cancer [PDF]
, 2011 Nestin, an intermediate filament protein, has traditionally been noted for its importance as a neural stem cell marker. However, in recent years, expression of nestin has shown to be associated with general proliferation of progenitor cell populations ...
B. Massidda +11 more
core +2 more sources
Triple-Negative Breast Cancer: Emerging Biomarkers for Early Diagnosis, Prognosis, and Treatment [PDF]
Middle East Journal of CancerBreast cancer (BC) is a heterogeneous disease characterized by significant global mortality and incidence rates. Annually, approximately 1 million cases of BC are diagnosed worldwide, with over 170,000 classified as triple-negative.
Zahra Roshanizadeh +2 more
doaj +1 more source